In search of the vulnerable plaque: Is there any light at the end of the catheter?

Journal of the American College of Cardiology

Volumn 64, Issue 23, 2014, Pages 2519-2524

  Kaul, Sanjay ^a,b   Narula, Jagat ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Predictive utility; Prognostic utility

Indexed keywords

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FRACTIONAL FLOW RESERVE; HUMAN; IMAGING SYSTEM; INTRAVASCULAR ULTRASOUND; LIPID COMPOSITION; NEAR INFRARED SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROGRAM FEASIBILITY; REVIEW; SECONDARY PREVENTION; SHEAR STRESS; SPECTROMETER; FEMALE; MALE; PATHOLOGY;

CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; SPECTROSCOPY, NEAR-INFRARED;

EID: 84926374918     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.10.017     Document Type: Editorial

References (20)

1. Garcia-Garcia HM, Jang IK, Serruys PW, et al. Imaging plaques to predict and better manage patients with acute coronary events. Circ Res 2014;114:1904-17.
2. Oemrawsingh RM, Cheng JM, García-García HM, et al. Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease. J Am Coll Cardiol 2014; 64:2510-8.
3. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Eng J Med 2011;364:226-35.
4. Calvert PA, Obaid DR, O'Sullivan M, et al. Association between virtual histology intravascular ultrasound findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study. J Am Coll Cardiol Img 2011;4:894-901.
5. Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study. Circulation 2012;126:172-81.
6. Cheng JM, Garcia-Garcia HM, de Boer SPM, et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMOIVUS study. Eur Heart J 2014;35:639-47.
7. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.
8. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001.
9. Goldstein JA, Maini B, Dixon SR. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv 2011;4:429-37.
10. Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow (CANARY Trial). (Abstract, TCT, September 2014). Available at: http://www.tctmd.com/show.aspx?id=125740. Accessed October 16, 2014.
11. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
12. Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013;62:1748-58.
13. Wykrzykowska JJ, Diletti R, Gutierrez-Chico JL, et al. Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCTderived TCFAs in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT). EuroIntervention 2012;8:945-54.
14. Rodes-Cabau J, Bertrand OF, Larose E, et al. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial. Can J Cardiol 2014;30:138-45.
15. Kini AS, Baber U, Kovacic JC, et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy. J Am Coll Cardiol 2013;62:21-9.
16. Raber L, Taniwaki M, Zaugg S, et al. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur Heart J 2014 Sep 2 [E-pub ahead of print].
17. Simsek C, Garcia-Garcia HM, van Geuns RJ, et al. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3). EuroIntervention 2012;8:235-41.
18. Serruys PW, García-García HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008; 118:1172-82.
19. The STABILITY Investigators. Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014;370:1702-11.
20. O'Donoghue ML, Braunwald E, White HD, et al. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA 2014;312:1006-15.